GlassScriptPhysician profile
Ann M Corey
NPI 1821359522
$2,561.54
in general payments reported to CMS, 2019-2025
14 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $465 · 2022: $482 · 2023: $572 · 2024: $510 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,540 · Education: $75.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.65 |
| Education | $75.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $912.90 | 2021-2025 | Qelbree, Qelbree |
| Abbvie INC. | $543.40 | 2021-2024 | |
| Sunovion Pharmaceuticals INC. | $188.94 | 2021-2022 | |
| Corium, LLC | $177.07 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $164.49 | 2021-2023 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $146.93 | 2023-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $101.98 | 2025 | Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $93.52 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $91.48 | 2022-2025 | Spravato |
| Vanda Pharmaceuticals INC. | $51.95 | 2024-2025 | Fanapt |
| Alkermes, INC. | $30.94 | 2022-2025 | Lybalvi |
| Tris Pharma INC | $28.87 | 2023-2024 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $16.37 | 2022 | |
| Axsome Therapeutics, INC. | $12.70 | 2023 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Corey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.